Trials / Completed
CompletedNCT01315054
A Methadone Maintenance Treatment Outcome Study in Three Provinces in China
A Methadone Maintenance Treatment Outcome Study in Three Provinces in China: Comparative Evaluation of the Impact of an Intensive Health Care Provider Training Program
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 4,258 (actual)
- Sponsor
- Centers for Disease Control and Prevention · Federal
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary goal of this PHE is to determine the effectiveness of a tailored education program for MMT service providers. It was to be evaluated through methadone dose levels prescribed to new patients after training completion. The effects of methadone dose, with and without the inclusion of additional counseling services, would be measured through MMT retention and illicit opioid use.
Detailed description
Methadone treatment has became one of main actions taken in China to control the spread of HIV among drug users. However,the average methadone dose used is relatively low. An intensive methadone maintenance treatment (MMT) provider training on methadone dosage may be effective in increasing the methadone dose levels prescribed to new patients. The study will evaluate the effectiveness of a tailored education program for MMT service providers using subsequent methadone dose prescribed to new patients. The effects of methadone dose, with and without the inclusion of additional psychosocial services, will then be measured through MMT retention and illicit opioid use.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | MMT provider dosage training | Training on methadone dosing provided to health care providers working in methadone maintenance clinics |
| BEHAVIORAL | targeted counseling | targeted counseling provided to methadone maintenance clinic attendees |
| OTHER | national guidelines | Provided a hard copy of the existing national guidelines for methadone dosing |
Timeline
- Start date
- 2011-05-01
- Primary completion
- 2015-12-01
- Completion
- 2018-12-01
- First posted
- 2011-03-15
- Last updated
- 2024-08-22
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT01315054. Inclusion in this directory is not an endorsement.